Enzymotec Company Profile (NASDAQ:ENZY)

About Enzymotec

Enzymotec logoEnzymotec Ltd. is a nutritional ingredients and medical foods company. The Company's technologies, research expertise and clinical validation process enables it to develop solutions across a range of products. The Company operates in two segments: Nutrition segment and VAYA Pharma segment. Both of the Company's segments offer a range of products that leverage its lipid-related offerings. Its product suite addresses the entire human life-cycle, from infancy to old age, and comprises ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor's supervision. It markets its product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. The Company's clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ENZY
  • CUSIP:
Key Metrics:
  • Previous Close: $6.94
  • 50 Day Moving Average: $7.19
  • 200 Day Moving Average: $8.04
  • 52-Week Range: $6.60 - $10.32
  • Trailing P/E Ratio: 36.53
  • Foreward P/E Ratio: 13.61
  • P/E Growth: 0.85
  • Market Cap: $157.67M
  • Outstanding Shares: 22,719,000
  • Beta: 1.27
  • Net Margins: 8.37%
  • Return on Equity: 3.12%
  • Return on Assets: 2.87%
  • Current Ratio: 7.64%
  • Quick Ratio: 5.36%
Additional Links:
Companies Related to Enzymotec:

Analyst Ratings

Consensus Ratings for Enzymotec (NASDAQ:ENZY) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $9.50 (36.89% upside)

Analysts' Ratings History for Enzymotec (NASDAQ:ENZY)
DateFirmActionRatingPrice TargetDetails
8/4/2016Jefferies GroupReiterated RatingHoldView Rating Details
4/17/2016Canaccord GenuityReiterated RatingHoldView Rating Details
8/13/2015Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Enzymotec (NASDAQ:ENZY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016Q216$0.08$0.04$14.90 million$15.00 millionViewN/AView Earnings Details
5/19/2016Q116$0.05$0.09$13.85 million$14.00 millionViewListenView Earnings Details
2/17/2016Q415$0.10$0.07$14.01 million$13.30 millionViewListenView Earnings Details
11/11/2015Q315$0.07$0.08$14.21 million$12.40 millionViewListenView Earnings Details
8/12/2015Q215$0.06$0.11$12.39 million$13.40 millionViewListenView Earnings Details
5/7/2015Q115$0.06$0.09$12.10 million$12.25 millionViewN/AView Earnings Details
2/18/2015Q414$0.08$0.06$11.11 million$10.80 millionViewN/AView Earnings Details
11/13/2014Q314$0.04$0.05$10.22 million$9.50 millionViewN/AView Earnings Details
8/5/2014Q214$0.10$0.02$14.88 million$11.50 millionViewN/AView Earnings Details
5/14/2014Q114$0.17$0.24$19.40 million$23.70 millionViewN/AView Earnings Details
2/13/2014Q413$0.11$0.15$11.64 million$18.51 millionViewN/AView Earnings Details
11/11/2013Q313$0.11$0.13$13.10 million$22.50 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Enzymotec (NASDAQ:ENZY)
Current Year EPS Consensus Estimate: $0.27 EPS
Next Year EPS Consensus Estimate: $0.51 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.05$0.05$0.05
Q2 20161$0.08$0.08$0.08
Q3 20161$0.06$0.06$0.06
Q4 20161$0.07$0.07$0.07
(Data provided by Zacks Investment Research)


Dividend History for Enzymotec (NASDAQ:ENZY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Enzymotec (NASDAQ:ENZY)
No insider trades for this company have been tracked by MarketBeat.com


Latest Headlines for Enzymotec (NASDAQ:ENZY)
News IconPhytosterols Market To Gain From Enhanced Demand In Various Application Sector As Cosmetics Till 2020: Grand View Research, Inc. (NASDAQ:ENZY)
www.abnewswire.com - October 24 at 10:04 AM
News IconNiela Magwood-Phoenix | Vaya Pharma (NASDAQ:ENZY)
thedailyrecord.com - October 4 at 9:41 AM
News IconKrill Oil Market driven by increasing health concerns among consumers (NASDAQ:ENZY)
www.medgadget.com - September 30 at 5:12 PM
4-traders.com logoNews Highlights : Top Financial Services News of the Day (NASDAQ:ENZY)
www.4-traders.com - September 28 at 4:44 PM
finance.yahoo.com logoEnzymotec Ltd. Granted New Patents for INFAT® in the U.S., Vayacog® in Japan and Phospholipid-Based Products in Canada and Korea (NASDAQ:ENZY)
finance.yahoo.com - September 27 at 9:25 AM
News IconWhere's Hogan? Updates from the governor's trade mission to Israel (NASDAQ:ENZY)
www.baltimoresun.com - September 21 at 5:21 PM
News IconNew non-GMO flaxseed oil brings huge potential (NASDAQ:ENZY)
www.fooddive.com - September 17 at 9:33 AM
openpr.com logoKrill Oil Market segmented into dietary supplements, functional food & beverages & others, Globally (NASDAQ:ENZY)
www.openpr.com - September 14 at 10:02 PM
newsmaker.com.au logoKrill Oil Market key trends, drivers, and restraints during 2016-2022 (NASDAQ:ENZY)
www.newsmaker.com.au - August 31 at 4:47 PM
publicnow.com logo2016-08-30 Enzymatica AB: The board of directors in Enzymatica has resolved on a directed share issue of SEK 40.3 million (NASDAQ:ENZY)
www.publicnow.com - August 30 at 12:27 PM
openpr.com logoExplore Krill Oil Market Size, Share and Industry Analysis by 2022 (NASDAQ:ENZY)
www.openpr.com - August 29 at 9:31 AM
finance.yahoo.com logoEdited Transcript of ENZY earnings conference call or presentation 9-Aug-16 12:30pm GMT (NASDAQ:ENZY)
finance.yahoo.com - August 19 at 3:58 PM
finance.yahoo.com logoShould You Get Rid of Enzymotec (ENZY) Now? (NASDAQ:ENZY)
finance.yahoo.com - August 18 at 4:51 PM
capitalcube.com logoEnzymotec Ltd. :ENZY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:ENZY)
www.capitalcube.com - August 15 at 4:58 PM
thestreet.com logoEnzymotec Ltd. Reports Second Quarter 2016 Unaudited Financial Results (NASDAQ:ENZY)
www.thestreet.com - August 10 at 5:03 PM
sg.finance.yahoo.com logoEnzymotec misses 2Q profit forecasts (NASDAQ:ENZY)
sg.finance.yahoo.com - August 9 at 3:32 PM
publicnow.com logoEnzymotec Ltd. To Present at Two Upcoming Investor Conferences (NASDAQ:ENZY)
www.publicnow.com - August 2 at 9:38 AM
publicnow.com logoEnzymotec to Report Second Quarter 2016 Financial Results (NASDAQ:ENZY)
www.publicnow.com - July 26 at 8:38 AM
publicnow.com logo2016-07-18 Enzymatica AB: Excellent volume growth for ColdZyme® (NASDAQ:ENZY)
www.publicnow.com - July 18 at 3:38 AM
einnews.com logoEnzymotec Ltd. Calls for its 2016 Annual General Meeting of Shareholders (NASDAQ:ENZY)
semiconductors.einnews.com - July 15 at 3:51 PM
publicnow.com logoCORRECTING and REPLACING -- Enzymotec Ltd. Calls its 2016 Annual General Meeting of Shareholders (NASDAQ:ENZY)
www.publicnow.com - July 13 at 5:18 PM
gurufocus.com logoJulian Robertson Sells Half of Stake in John Paulson-Backed Company (NASDAQ:ENZY)
www.gurufocus.com - July 3 at 9:25 AM
finance.yahoo.com logoJulian Robertson Cuts Half of Stake in Paulson-Backed Company (NASDAQ:ENZY)
finance.yahoo.com - July 1 at 7:16 PM
insidermonkey.com logoEnzymotec (ENZY): Julian Robertson’s Tiger Management Dumps Half of Its Stake (NASDAQ:ENZY)
www.insidermonkey.com - July 1 at 12:38 PM
newsmaker.com.au logoBaby Nutrition Market Insights Analyse of Current and Forecast Industry Position in 2016 Report- Issue 27 (NASDAQ:ENZY)
www.newsmaker.com.au - June 14 at 4:45 PM
sbwire.com logoGlobal Global Krill Oil Market to Reach US $703.0 Mn by 2022 : PMR (NASDAQ:ENZY)
www.sbwire.com - June 6 at 4:45 PM
News IconPhytosterols Market Size Estimated to Reach $989.8 Million by 2020: Grand View Research, Inc. (NASDAQ:ENZY)
andhranews.net - June 6 at 4:45 PM
newsmaker.com.au logoKrill Oil Market will hit US$ 703.0 Mn by 2022, Globally : PMR Report (NASDAQ:ENZY)
www.newsmaker.com.au - June 2 at 5:01 PM
News IconEnzymotec Limited Ord (NASDAQ:ENZY) Shorted Shares Decreased By 32.77% - HNN (NASDAQ:ENZY)
hintsnewsnetwork.com - May 28 at 7:56 PM
News IconEarnings Review and Stock Rundown for Enzymotec Ltd. (NASDAQ:ENZY) - Wall Street Hints and News (NASDAQ:ENZY)
hintsnewsnetwork.com - May 27 at 8:23 PM
tradecalls.org logoRevenue Update on Enzymotec Ltd(NASDAQ:ENZY) - Trade Calls (NASDAQ:ENZY)
www.tradecalls.org - May 26 at 8:13 PM
publicnow.com logo2016-05-25 Bulletin from the Annual General Meeting in Enzymatica AB (publ) (NASDAQ:ENZY)
www.publicnow.com - May 25 at 8:46 AM
capitalcube.com logoEnzymotec Ltd. :ENZY-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 (NASDAQ:ENZY)
www.capitalcube.com - May 23 at 1:55 PM
News IconAfter Last Week What Do Analysts Think Of Enzymotec Ltd. (NASDAQ:ENZY) - Share Trading News (NASDAQ:ENZY)
www.sharetrading.news - May 22 at 7:26 PM
News IconHow Many Enzymotec Ltd (NASDAQ:ENZY)'s Analysts Are Bearish? - Wall Street Hints and News (NASDAQ:ENZY)
hintsnewsnetwork.com - May 22 at 12:44 PM
globenewswire.com logoEnzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results - GlobeNewswire (press release) (NASDAQ:ENZY)
globenewswire.com - May 21 at 1:05 AM
News IconLatest Analyst Ratings For Enzymotec Ltd. (NASDAQ:ENZY) - Share Trading News (NASDAQ:ENZY)
www.sharetrading.news - May 20 at 7:58 PM
finance.yahoo.com logoEdited Transcript of ENZY earnings conference call or presentation 19-May-16 12:30pm GMT (NASDAQ:ENZY)
finance.yahoo.com - May 20 at 11:33 AM
twst.com logoEnzymotec Ltd.: Enzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results - The Wall Street Transcript (NASDAQ:ENZY)
www.twst.com - May 20 at 1:12 AM
reuters.com logoBRIEF-Enzymotec Ltd Q1 non-gaap earnings per share $0.09 - Reuters (NASDAQ:ENZY)
www.reuters.com - May 19 at 7:59 PM
sbwire.com logoKrill Oil Market Has Been Estimated to Be Valued at US$ 300.7 Mn by the End of 2015, Globally (NASDAQ:ENZY)
www.sbwire.com - May 19 at 7:59 PM
reuters.com logoBRIEF-Enzymotec Ltd Q1 non-gaap earnings per share $0.09 (NASDAQ:ENZY)
www.reuters.com - May 19 at 7:59 PM
publicnow.com logoEnzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results (NASDAQ:ENZY)
www.publicnow.com - May 19 at 8:32 AM
sg.finance.yahoo.com logoEnzymotec beats 1Q profit forecasts (NASDAQ:ENZY)
sg.finance.yahoo.com - May 19 at 7:55 AM
finance.yahoo.com logo7:42 am Enzymotec beats by $0.04, reports revs in-line; reaffirms FY16 EPS guidance, revs guidance (NASDAQ:ENZY)
finance.yahoo.com - May 19 at 7:42 AM
biz.yahoo.com logoQ1 2016 Enzymotec Ltd Earnings Release - Before Market Open (NASDAQ:ENZY)
biz.yahoo.com - May 19 at 7:07 AM
investornewswire.com logoAlpha One Assigns Impact Score Of 100 To Enzymotec Ltd. (NASDAQ:ENZY) - Investor Newswire (NASDAQ:ENZY)
www.investornewswire.com - May 17 at 7:44 PM
4-traders.com logoEnzymotec Ltd : quaterly earnings release (NASDAQ:ENZY)
www.4-traders.com - May 16 at 1:23 PM
News IconPerformance Recap and Target Perspective on Enzymotec Ltd. (NASDAQ:ENZY) - B.O.D.Y Confidential (NASDAQ:ENZY)
www.bodyconfidential.com - May 11 at 8:43 PM
publicnow.com logo2016-05-11 Enzymatica's new rights issue completed - will be provided with SEK 60 million (NASDAQ:ENZY)
www.publicnow.com - May 11 at 6:42 AM


Enzymotec (NASDAQ:ENZY) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by MarketBeat.com Staff